Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Innovation Pharmaceuticals Inc (IPIX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12100
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetrin for the treatment of advanced solid tumors and acute myelogenous leukemia, among others. It offers pipeline products such as Brilacidin for the treatment of oral mucositis and skin infections; and Prurisol for the treatment of psoriasis. Innovation Pharmaceuticals works in collaboration with various research institutions across the US and other European countries. The company operates in the US. Innovation Pharmaceuticals is headquartered in Beverly, Massachusetts, the US.

Innovation Pharmaceuticals Inc (IPIX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovation Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Innovation Pharma to Raise up to USD10 Million in Private Placement of Shares 10
Innovation Pharma Raises USD2 Million in Private Placement of Shares 11
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 12
Cellceutix Raises USD16 Million in Private Placement of Common Stock 13
Acquisition 14
Cellceutix Completes Acquisition Of PolyMedix 14
Innovation Pharmaceuticals Inc – Key Competitors 15
Innovation Pharmaceuticals Inc – Key Employees 16
Innovation Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Feb 16, 2017: Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones 18
Legal and Regulatory 20
Jun 07, 2017: Cellceutix Announces Company Name Change to Innovation Pharmaceuticals 20
Other Significant Developments 21
Sep 20, 2018: Innovation Pharmaceuticals provides corporate update highlighting upcoming milestones and events 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Innovation Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovation Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovation Pharma to Raise up to USD10 Million in Private Placement of Shares 10
Innovation Pharma Raises USD2 Million in Private Placement of Shares 11
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 12
Cellceutix Raises USD16 Million in Private Placement of Common Stock 13
Cellceutix Completes Acquisition Of PolyMedix 14
Innovation Pharmaceuticals Inc, Key Competitors 15
Innovation Pharmaceuticals Inc, Key Employees 16

List of Figures
Innovation Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovation Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovation Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enthera Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Enthera Srl (Enthera), a subsidiary of BiovelocITA Srl, is a biotechnology company, which strives to discover novel medicines for the treatment of diabetes and related gastrointestinal disorders. Gastrointestinal symptoms such as diarrhea and abdominal pain among diabetics are referred to as …
  • Klepierre SA:企業のM&A・事業提携・投資動向
    Klepierre SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Klepierre SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Centogene AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • The Bank Of East Asia, Limited:企業の戦略・SWOT・財務分析
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Arag Group
    The Arag Group - Strategy, SWOT and Corporate Finance Report Summary The Arag Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Liburnia Riviera Hoteli d.d.:企業の戦略・SWOT・財務情報
    Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report Summary Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. Its major products include tests functional assa …
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報
    Summary Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as we …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Toshiba Corporation:企業のM&A・事業提携・投資動向
    Toshiba Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toshiba Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Spine Injury Solutions Inc (SPIN):企業の財務・戦略的SWOT分析
    Summary Spine Injury Solutions Inc (SPIN), formerly Spine Pain Management Inc is a medical service provider that provides medical technology and healthcare management solutions for liability spine injuries. The company provides services such as clinical management, and billing and collection of medi …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Mphasis Limited:企業の戦略・SWOT・財務分析
    Mphasis Limited - Strategy, SWOT and Corporate Finance Report Summary Mphasis Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HNZ Group Inc.:戦略・SWOT・企業財務分析
    HNZ Group Inc. - Strategy, SWOT and Corporate Finance Report Summary HNZ Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆